Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Rating) EVP Myriam Curet sold 6,000 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, April 26th. The shares were sold at an average price of $252.51, for a total transaction of $1,515,060.00. Following the completion of the transaction, the executive vice president now owns 361 shares of the company’s stock, valued at approximately $91,156.11. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.
Myriam Curet also recently made the following trade(s):
- On Wednesday, February 16th, Myriam Curet sold 2,478 shares of Intuitive Surgical stock. The shares were sold at an average price of $289.00, for a total transaction of $716,142.00.
Shares of ISRG stock opened at $235.35 on Thursday. Intuitive Surgical, Inc. has a 12-month low of $235.07 and a 12-month high of $369.69. The firm has a market capitalization of $84.54 billion, a price-to-earnings ratio of 52.34, a price-to-earnings-growth ratio of 7.15 and a beta of 1.17. The firm has a fifty day moving average of $283.99 and a 200-day moving average of $312.87.
A number of research analysts have recently issued reports on ISRG shares. BTIG Research cut their target price on shares of Intuitive Surgical from $372.00 to $360.00 and set a “buy” rating for the company in a research note on Friday, January 21st. UBS Group raised shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and raised their price target for the company from $317.00 to $325.00 in a report on Wednesday, February 2nd. Wolfe Research initiated coverage on shares of Intuitive Surgical in a report on Tuesday, April 5th. They issued a “peer perform” rating and a $315.00 price target for the company. Citigroup raised shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and lowered their price target for the company from $370.00 to $360.00 in a report on Friday, January 21st. Finally, Robert W. Baird lowered their price target on shares of Intuitive Surgical from $370.00 to $315.00 and set an “outperform” rating for the company in a report on Friday, January 21st. Eight research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, Intuitive Surgical presently has an average rating of “Buy” and an average price target of $326.60.
Several hedge funds have recently made changes to their positions in ISRG. Hexagon Capital Partners LLC lifted its position in Intuitive Surgical by 200.0% in the 4th quarter. Hexagon Capital Partners LLC now owns 69 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 46 shares in the last quarter. Paragon Capital Management Ltd bought a new stake in Intuitive Surgical in the 4th quarter valued at $26,000. Hanseatic Management Services Inc. lifted its position in Intuitive Surgical by 200.0% in the 4th quarter. Hanseatic Management Services Inc. now owns 72 shares of the medical equipment provider’s stock valued at $26,000 after acquiring an additional 48 shares in the last quarter. Standard Family Office LLC bought a new stake in Intuitive Surgical in the 4th quarter valued at $27,000. Finally, Wolff Wiese Magana LLC lifted its position in Intuitive Surgical by 1,000.0% in the 4th quarter. Wolff Wiese Magana LLC now owns 77 shares of the medical equipment provider’s stock valued at $28,000 after acquiring an additional 70 shares in the last quarter. 44.03% of the stock is owned by institutional investors.
Intuitive Surgical Company Profile (Get Rating)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
- Get a free copy of the StockNews.com research report on Intuitive Surgical (ISRG)
- Automatic Data Processing Is Ready To Scale New Heights
- Carl Icahn Buys More Xerox
- Xerox Holdings Stock is a Value Play
- The Kraft Heinz Turnaround Story Gains Momentum
- Microsoft (NASDAQ: MSFT) Saves The Day, For Now
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.